3 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 3 |
Follow Rhinitis, Allergic: new trials by email Literature Review of Rhinitis, Allergic trials Research Report on Rhinitis, Allergic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). GR1802 injection, Placebo - Allergic Rhinitis | Phase 2 | Active not recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 240 | 2024-03-24 | 2025-04-25 |
| Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS) Tezepelumab - Asthma With Allergic Rhinitis | Phase 2 | Active not recruiting | Dr. Anne Ellis | 19 | 2024-01-29 | 2026-01-20 |
| Dupilumab Effects Against Aeroallergen Challenge Dupilumab, House Dust Mites (HDM), Placebo - Asthma, Allergic | Phase 2 | Active not recruiting | The University of Texas Health Science Center at San Antonio | 96 | 2023-03-29 | 2026-08-11 |
Asthma (1) · Dust Mite Allergy (1) · Hypersensitivity (1) · Rhinitis, Allergic, Seasonal (1)
Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Nose Diseases (3) · Otorhinolaryngologic Diseases (3) · Respiratory Hypersensitivity (3) · Respiratory Tract Diseases (3) · Rhinitis (3) · Hypersensitivity (2) · Bronchial Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Rhinitis, Allergic, Perennial (1)
Antigens, Dermatophagoides (1) · dupilumab (1) · tezepelumab (1)
Dr. Anne Ellis (1) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. (1) · The University of Texas Health Science Center at San Antonio (1)
Canada (1) · China (1) · United States (1)
Anne K Ellis, MD (1) · Sunil K Ahuja, MD (1) · Zheng Liu, PHD (1)
U01AI158460 (1)